AI Insight
A study of over 500,000 older adults found that those who received the Shingrix shingles vaccine had a 24% lower risk of being diagnosed with dementia over a four-year follow-up period compared to unvaccinated individuals. The researchers estimate this translates to approximately one dementia case prevented for every 17 people who receive the vaccine.
Why it matters
This finding suggests a potential new avenue for dementia prevention through vaccination, though the mechanism behind this association requires further investigation. If confirmed through additional research, routine shingles vaccination could have significant public health implications for reducing dementia incidence in aging populations.
Understand the Science
Older adults who received the Shingrix shingles vaccine were 24% less likely to be diagnosed with dementia over four years in a study of more than 500,000 people. Researchers estimate the difference could amount to roughly one dementia case prevented for every 17 people vaccinated.